Bradley Foster & Sargent’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-740	Closed	-$204K	–	543
2025 Q4	$204K	Sell	740 -41	-5%	-$11.2K	﹤0.01%	521
2025 Q3	$205K	Buy	+781	New	+$190K	﹤0.01%	529
2025 Q1	–	Sell	-829	Closed	-$272K	–	476
2024 Q4	$272K	Buy	+829	New	+$261K	﹤0.01%	424
2024 Q2	–	Sell	-554	Closed	-$219K	–	462
2024 Q1	$219K	Buy	+554	New	+$205K	﹤0.01%	425
2023 Q4	–	Sell	-779	Closed	-$298K	–	447
2023 Q3	$298K	Hold	779	–	–	0.01%	390
2023 Q2	$298K	Sell	779 -55	-7%	-$19.6K	0.01%	390
2023 Q1	$289K	Buy	+834	New	+$244K	0.01%	380
2022 Q4	–	Sell	-1,709	Closed	-$421K	–	442
2022 Q3	$421K	Sell	1,709 -6	-0.3%	-$1.83K	0.01%	333
2022 Q2	$519K	Buy	1,715 +490	+40%	+$159K	0.01%	322
2022 Q1	$503K	Hold	1,225	–	–	0.01%	348
2021 Q4	$575K	Sell	1,225 -25	-2%	-$10.8K	0.01%	310
2021 Q3	$531K	Sell	1,250 -25	-2%	-$10.5K	0.01%	297
2021 Q2	$458K	Hold	1,275	–	–	0.01%	319
2021 Q1	$359K	Sell	1,275 -75	-6%	-$21.5K	0.01%	322
2020 Q4	$382K	Sell	1,350 -75	-5%	-$21K	0.01%	317
2020 Q3	$392K	Buy	+1,425	New	+$377K	0.01%	274
2020 Q1	$217K	Sell	1,425 -100	-7%	-$15.4K	0.01%	308
2019 Q4	$229K	Sell	1,525 -100	-6%	-$14.6K	0.01%	341
2019 Q3	$230K	Hold	1,625	–	–	0.01%	323
2019 Q2	$203K	Buy	+1,625	New	+$192K	0.01%	340
2018 Q4	–	Sell	-1,700	Closed	-$210K	–	369
2018 Q3	$210K	Buy	+1,700	New	+$191K	0.01%	353
2017 Q4	–	Sell	-2,240	Closed	-$216K	–	362
2017 Q3	$216K	Hold	2,240	–	–	0.01%	343
2017 Q2	$212K	Buy	+2,240	New	+$206K	0.01%	334